Tax exemptions provided by the National Board of Revenue (NBR) are estimated to rise to Tk 163,000 crore in fiscal 2024-25 as the tax administration looks to ease the pressure on individuals and facilitate higher economic growth.
Experts and businesspeople also highlighted the challenges linked with the current tax and incentive system.
The National Board of Revenue seeks to impose 25 percent import duty on cars for lawmakers, reversing a practice of tax exemptions that amounted to Tk 5,147 crore over the last 15 years.
NBR has extended tax exemptions on interest income of foreign lenders who have lent to local firms until December 31, 2024
Known knowns -- is what best sums up the prognosis of the visiting International Monetary Fund mission so far as it looks to thrash out the conditions for the prospective $4.5 billion loan.
This newspaper ran two reports yesterday that revealed a positive picture of the economy's future. The first one describes the government's plan to provide a handful of incentives including tax exemptions to the pharmaceutical ingredients manufacturers, with a view to capitalising on the patent waiver for the manufacture of pharmaceutical products extended to the least developed countries.
Tax exemptions provided by the National Board of Revenue (NBR) are estimated to rise to Tk 163,000 crore in fiscal 2024-25 as the tax administration looks to ease the pressure on individuals and facilitate higher economic growth.
Experts and businesspeople also highlighted the challenges linked with the current tax and incentive system.
The National Board of Revenue seeks to impose 25 percent import duty on cars for lawmakers, reversing a practice of tax exemptions that amounted to Tk 5,147 crore over the last 15 years.
NBR has extended tax exemptions on interest income of foreign lenders who have lent to local firms until December 31, 2024
Known knowns -- is what best sums up the prognosis of the visiting International Monetary Fund mission so far as it looks to thrash out the conditions for the prospective $4.5 billion loan.
This newspaper ran two reports yesterday that revealed a positive picture of the economy's future. The first one describes the government's plan to provide a handful of incentives including tax exemptions to the pharmaceutical ingredients manufacturers, with a view to capitalising on the patent waiver for the manufacture of pharmaceutical products extended to the least developed countries.